Two‐sample inference procedures under nonproportional hazards

Author:

Tai Yi‐Cheng1ORCID,Wang Weijing1ORCID,Wells Martin T.2ORCID

Affiliation:

1. Institute of Statistics National Yang Ming Chiao Tung University Hsin‐Chu City Taiwan, ROC

2. Department of Statistics and Data Science Cornell University Ithaca New York USA

Abstract

AbstractWe introduce a new two‐sample inference procedure to assess the relative performance of two groups over time. Our model‐free method does not assume proportional hazards, making it suitable for scenarios where nonproportional hazards may exist. Our procedure includes a diagnostic tau plot to identify changes in hazard timing and a formal inference procedure. The tau‐based measures we develop are clinically meaningful and provide interpretable estimands to summarize the treatment effect over time. Our proposed statistic is a U‐statistic and exhibits a martingale structure, allowing us to construct confidence intervals and perform hypothesis testing. Our approach is robust with respect to the censoring distribution. We also demonstrate how our method can be applied for sensitivity analysis in scenarios with missing tail information due to insufficient follow‐up. Without censoring, Kendall's tau estimator we propose reduces to the Wilcoxon‐Mann–Whitney statistic. We evaluate our method using simulations to compare its performance with the restricted mean survival time and log‐rank statistics. We also apply our approach to data from several published oncology clinical trials where nonproportional hazards may exist.

Funder

Ministry of Science and Technology, Taiwan

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Reference37 articles.

1. ICH E9 working group.ICH E9 (R1): Addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials.2020https://www.ema.europa.eu/documents/scientific-guideline/draft-ich-e9-r1-addendum-estimands-sensitivity-analysis-clinical-trials-guideline-statistical_en.pdf

2. Treatment effect quantification for time‐to‐event endpoints–Estimands, analysis strategies, and beyond

3. Methods for Accommodating Nonproportional Hazards in Clinical Trials: Ready for the Primary Analysis?

4. Testing for Differences in Survival When Treatment Effects Are Persistent, Decaying, or Delayed

5. Estimating Treatment Effect as the Primary Analysis in a Comparative Study: Moving Beyond P Value

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3